SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors

出版年份 2019 全文链接

标题

作者

关键词

targeted therapies, adaptive resistance, ERK signaling, SHP2, RTK signaling, RAS, BRAF, MEK, FGFR, triple-negative breast cancer, TNBC

出版物

Volume 26, Issue 1, Pages 65-78.e5

出版商

Elsevier BV

发表日期

2019-01-02

DOI

10.1016/j.celrep.2018.12.013

联系作者

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now